Post-Conference Perspectives: Updates in HER2+ Metastatic Breast Cancer; ASCO 2023 Highlights
home / news-network / post-conference-perspectives-updates-in-her2-metastatic-breast-cancer-asco-2023-highlights
Megan Kruse, MD, reviews updates from the 2023 ASCO Annual Meeting and offers insights onthe evolving treatment landscape for HER2+ metastatic breast cancer.